Both F@-isoprostane ( @-iso-PGF@a ) and oxidized low-density lipoprotein ( ox-LDL ) have emerged as biomarkers of oxidative stress and have been proposed as useful biomarkers that could potentially be used as indicators of cardiovascular disease .